LYELL IMMUNOPHARMA INC
LYEL·55083R203·US·Common Stock·Healthcare - Biotechnology-13D/G
LYEL (LYELL IMMUNOPHARMA INC) is held by 47 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($14.4M), MILLENNIUM MANAGEMENT LLC ($9.2M), CITADEL ADVISORS LLC ($7.7M). Net institutional sentiment: Bullish.
47
Holders
Avg rating(6 Elite)
$73.3M
Total Value
76% (51)
Fund Consensus
32 buying - 10 selling
Who's Trading
ActivistICInnovative Cellular Therapeutics Holdings Limited12.3%Jun 18, 2026
InsiderSDShook DavidSell $25KJun 10, 2026
ActivistAVARCH Venture Fund IX, L.P.13.9%May 15, 2026
InsiderHJHill Stephen J.Sell $2KMay 11, 2026
InsiderLKLee Gary K.Sell $2KMay 11, 2026
InsiderBSBulis Veronica SanchezSell $4KMay 11, 2026
ActivistMCMWG Caph Ltd4.3%May 11, 2026
ActivistEIExplore Investments LLC6.6%May 8, 2026
ActivistEUEULER FUND, L.P.6.7%Apr 21, 2026
InsiderALARCH Venture Fund XIII, L.P.Buy $12.5MMar 6, 2026
13F: Insider & Congress:
Showing 1-20 of 51
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer